NDUFS3 Gene - NADH:Ubiquinone Oxidoreductase Core Subunit S3

NDUFS3 Gene - NADH:Ubiquinone Oxidoreductase Core Subunit S3

Introduction

<div class="infobox infobox-gene">
<h3>NDUFS3</h3>
<table>
<tr><th>Full Name</th><td>NADH:Ubiquinone Oxidoreductase Core Subunit S3</td></tr>
<tr><th>Chromosomal Location</th><td>19p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[4714](https://www.ncbi.nlm.nih.gov/gene/4714)</td></tr>
<tr><th>OMIM</th><td>[601446](https://omim.org/entry/601446)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000103245</td></tr>
<tr><th>UniProt</th><td>[O75489](https://www.uniprot.org/uniprot/O75489)</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Leigh Syndrome, Mitochondrial Complex I Deficiency</td></tr>
</table>
</div>

Overview

NDUFS3 (NADH:Ubiquinone Oxidoreductase Core Subunit S3) encodes a core component of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the largest enzyme complex of the electron transport chain[@kirby2004]. Located on chromosome 19p13.3, NDUFS3 is essential for complex I assembly and function, and its dysfunction is directly linked to neurodegenerative diseases including Parkinson's disease (PD)[@schapira2012], [@subramaniam2018].

NDUFS3 Gene - NADH:Ubiquinone Oxidoreductase Core Subunit S3

Introduction

<div class="infobox infobox-gene">
<h3>NDUFS3</h3>
<table>
<tr><th>Full Name</th><td>NADH:Ubiquinone Oxidoreductase Core Subunit S3</td></tr>
<tr><th>Chromosomal Location</th><td>19p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[4714](https://www.ncbi.nlm.nih.gov/gene/4714)</td></tr>
<tr><th>OMIM</th><td>[601446](https://omim.org/entry/601446)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000103245</td></tr>
<tr><th>UniProt</th><td>[O75489](https://www.uniprot.org/uniprot/O75489)</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Leigh Syndrome, Mitochondrial Complex I Deficiency</td></tr>
</table>
</div>

Overview

NDUFS3 (NADH:Ubiquinone Oxidoreductase Core Subunit S3) encodes a core component of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the largest enzyme complex of the electron transport chain[@kirby2004]. Located on chromosome 19p13.3, NDUFS3 is essential for complex I assembly and function, and its dysfunction is directly linked to neurodegenerative diseases including Parkinson's disease (PD)[@schapira2012], [@subramaniam2018].

Complex I (NADH:ubiquinone oxidoreductase) is the entry point of the mitochondrial electron transport chain, catalyzing the transfer of electrons from NADH to ubiquinone while pumping protons across the inner mitochondrial membrane[@devires2016]. The resulting proton gradient drives ATP synthesis via ATP synthase. NDUFS3 encodes the 30 kDa iron-sulfur subunit located in the Q module of the hydrophilic arm, positioned near the electron entry point[@zago2018]. This strategic location makes NDUFS3 critical for both complex I assembly and catalytic efficiency.

Protein Structure and Function

Structural Organization

NDUFS3 is a 30 kDa protein belonging to the nuclear-encoded mitochondrial complex I subunits. It contains conserved iron-sulfur (Fe-S) cluster binding motifs essential for electron transfer[@wiedemann2018]:

• N-terminal domain: Contains the mitochondrial targeting sequence for import
• Core domain: Houses two [2Fe-2S] iron-sulfur clusters (N1a and N1b) responsible for electron transfer
• Interface region: Contacts neighboring core subunits (NDUFS2, NDUFV1, NDUFV2) to form the catalytic module

Catalytic Mechanism

NDUFS3 participates in the electron transfer chain within complex I:

The iron-sulfur clusters in NDUFS3 are essential for mediating electron flow between the FMN and ubiquinone reaction centers[@devires2016]. Loss or damage to NDUFS3 disrupts this chain, causing electron leakage and increased [reactive oxygen species (ROS)](/entities/reactive-oxygen-species) production.

Role in Parkinson's Disease Pathogenesis

Evidence from PD Patients

Multiple studies have documented complex I deficiency in the [substantia nigra](/brain-regions/substantia-nigra) of PD patients[@schapira2012], [@alauddin2023], [@lax2012]:

• Biochemical studies: Complex I activity is reduced by 30-40% in PD substantia nigra pars compacta neurons[@schapira2012]
• Postmortem analysis: NDUFS3 protein levels and complex I assembly are impaired in PD brains[@zago2018]
• Genetic associations: Rare variants in complex I subunits, including NDUFS3, have been identified in PD cohorts[@filograna2021]
• Sporadic PD: The majority of PD cases show complex I dysfunction even without identified genetic mutations[@schapira2012]

Mechanisms Linking NDUFS3 Dysfunction to PD

The connection between NDUFS3/complex I deficiency and PD neurodegeneration involves multiple interconnected pathways[@pickrell2015], [@perier2012]:

1. Energy Crisis

Complex I deficiency severely impairs oxidative phosphorylation[@malpolonia2015]. Dopaminergic neurons of the substantia nigra have exceptionally high energy demands due to their autonomous pacemaking activity and extensive axonal arborization. Loss of complex I function leads to:

• ATP depletion: Reduced ATP production impairs ion pump function and neurotransmitter synthesis
• NAD+/NADH imbalance: Disrupted redox state affects sirtuin signaling and DNA repair
• Synaptic dysfunction: Energy failure disrupts neurotransmitter release and synaptic vesicle recycling[@perier2012]

2. Oxidative Stress

Electron leakage from damaged complex I generates superoxide radicals[@pickrell2015], [@chen2010]:

• Superoxide production: Complex I dysfunction increases superoxide (O2-) generation
• Mitochondrial DNA damage: ROS damages mtDNA, which encodes critical respiratory chain subunits
• Protein oxidation: ROS modifies proteins including alpha-synuclein, promoting its aggregation
• Lipid peroxidation: ROS attacks mitochondrial cardiolipin, further disrupting membrane integrity[@burt2013]

3. Alpha-Synuclein Connection

NDUFS3 dysfunction and alpha-synuclein pathology form a vicious cycle[@kuwahara2018]:

• Oxidative stress promotes alpha-synuclein misfolding and aggregation
• Aggregated alpha-synucleinlocalizes to mitochondria, further inhibiting complex I
• Mitochondrial complex I inhibition increases alpha-synuclein aggregation propensity
• This creates a feedforward loop driving progressive neurodegeneration[@pickrell2015]

4. Mitophagy Dysregulation

The [PINK1/Parkin mitophagy pathway](/mechanisms/pink1-parkin-pathway) is intimately connected to complex I function[@ryan2012]:

• Damaged mitochondria with low membrane potential accumulate PINK1 on the outer membrane
• PINK1 activates Parkin E3 ubiquitin ligase activity
• Parkin ubiquitinates mitochondrial proteins, targeting the organelle for autophagic degradation
• Complex I deficiency can trigger compensatory mitophagy but also disrupts the signaling cascade
• PINK1 mutations (a genetic cause of PD) impair the cell's ability to remove damaged complex I[@pickrell2015]

Animal Models

NDUFS3 dysfunction has been modeled in several systems[@jensen2020]:

• Knockdown in Drosophila: Reduced NDUFS3 expression causes complex I deficiency, locomotor impairment, and shortened lifespan
• Conditional knockout in mice: Neuron-specific NDUFS3 deletion leads to progressive neurodegeneration with alpha-synuclein aggregation
• MPTP/rotenone models: These complex I inhibitors reproduce many features of NDUFS3 deficiency, validating the mechanistic link

Therapeutic Implications

Targeting complex I dysfunction remains an active therapeutic strategy[@barker2022], [@jensen2020]:

• Coenzyme Q10 (CoQ10): Electron carrier that bypasses complex I; clinical trials show modest benefit in early PD
• Nicotinamide riboside (NR): Boosts NAD+ levels, supporting mitochondrial biogenesis and sirtuin activity
• Mitochondrial-targeted antioxidants: MitoQ and other mitochondrial-specific ROS scavengers
• PGC-1α activators: Promote mitochondrial biogenesis to compensate for defective complexes
• Gene therapy approaches: Viral delivery of wild-type complex I subunits to restore function

NDUFS3 and Leigh Syndrome

NDUFS3 mutations were first identified as a cause of isolated complex I deficiency presenting as Leigh syndrome[@kirby2004], [@filograna2021]:

• Clinical features: Hypotonia, developmental regression, Leigh syndrome lesions in brainstem and basal ganglia
• Inheritance: Autosomal recessive; patients inherit two mutant alleles
• Biochemistry: Severely reduced complex I activity (typically <10% of normal)
• Prognosis: Variable; some patients respond to metabolic support and dietary interventions

Expression Pattern and Regulation

NDUFS3 shows tissue-specific expression patterns[@burt2013]:

• High expression: Brain (particularly substantia nigra, [hippocampus](/brain-regions/hippocampus), cortex), heart, skeletal muscle — tissues with high energy demands
• Moderate expression: Kidney, liver, pancreas
• Regulation: NDUFS3 expression is regulated by:
• PGC-1α: The master regulator of mitochondrial biogenesis drives NDUFS3 transcription
• AMPK: Energy sensor activated by low ATP, promotes mitochondrial gene expression
• SIRT1: NAD+-dependent deacetylase that activates PGC-1α under stress[@malpolonia2015]

Interaction Network

NDUFS3 interacts with multiple proteins within the mitochondrial complex I assembly[@wiedemann2018], [@zago2018]:

| Partner | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| NDUFS2 | Core subunit complex | Forms catalytic core with NDUFS3 |
| NDUFV1 | Core subunit complex | FMN to Fe-S electron transfer |
| NDUFV2 | Core subunit complex | Electron entry point |
| NDUFS1 | Core subunit complex | Q module assembly |
| NDUFS4 | Assembly factor | Critical for NDUFS3 incorporation |
| NDUFS6 | Assembly factor | Early assembly step |
| NDUFA9 | Assembly factor | Q module formation |
| LRPPRC | Transcriptional regulator | Mitochondrial DNA maintenance |

Differential Expression in Neurodegeneration

RNA sequencing and proteomics studies reveal NDUFS3 alterations across neurodegenerative diseases[@morradottir2019]:

• Alzheimer's disease: Reduced NDUFS3 transcript in hippocampus and cortex; correlates with mitochondrial dysfunction markers
• Parkinson's disease: Decreased NDUFS3 protein and activity in substantia nigra dopaminergic neurons
• Huntington's disease: NDUFS3 dysregulation in striatal neurons; mitochondrial deficit contributes to medium spiny neuron death
• Amyotrophic lateral sclerosis (ALS): Motor neuron complex I dysfunction including NDUFS3 abnormalities

Research History

| Year | Milestone |
|------|-----------|
| 1999 | NDUFS3 gene identified and mapped to chromosome 19p13.3 |
| 2004 | First NDUFS3 mutations identified causing Leigh syndrome[@kirby2004] |
| 2009 | NDUFS3/complex I deficiency documented in PD substantia nigra[@gandhi2009] |
| 2012 | Comprehensive review of complex I defects in neurodegeneration[@lax2012], [@blic2013] |
| 2015 | PINK1/Parkin pathway interactions with complex I elucidated[@pickrell2015] |
| 2016 | Structural insights into NDUFS3 function within complex I[@devires2016] |
| 2018 | Alpha-synuclein and complex I dysfunction feedforward loop described[@kuwahara2018] |
| 2021 | NDUFS3 promoter variants associated with PD risk[@filograna2021] |
| 2022 | CoQ10 clinical trials in complex I-deficient PD patients[@barker2022] |
| 2023 | Single-cell analysis of complex I deficiency in PD dopaminergic neurons[@alauddin2023] |

See Also

• [Mitochondrial Complex I](/mechanisms/mitochondrial-complex-i)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Leigh Syndrome](/diseases/leigh-syndrome)
• [PINK1/Parkin Pathway](/mechanisms/pink1-parkin-pathway)
• [Alpha-Synuclein Aggregation](/mechanisms/alpha-synuclein-aggregation)
• [Neurodegeneration and Mitochondria](/mechanisms/mitochondria-neurodegeneration)

External Links

• [NCBI Gene: NDUFS3](https://www.ncbi.nlm.nih.gov/gene/4714)
• [OMIM: 601446](https://omim.org/entry/601446)
• [UniProt: O75489](https://www.uniprot.org/uniprot/O75489)
• [PubMed: NDUFS3 neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=NDUFS3+Parkinson)
• [GeneCards: NDUFS3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NDUFS3)

Pathway Diagram

The following diagram shows the key molecular relationships involving NDUFS3 Gene - NADH:Ubiquinone Oxidoreductase Core Subunit S3 discovered through SciDEX knowledge graph analysis: